Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
17 May 2023 - 7:00AM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number: 001-39137
Fresh2 Group Limited
650 5TH AVE STE 2416
NEW YORK, NY 10019-6108
United States
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXPLANATORY NOTE
On May 16, 2023, the Registrant issued (i) a press
release reporting the consolidated financial statements for the year ended December 31, 2022, (ii) a press release reporting the unaudited
financial results for the three months ended March 31, 2023, and (iii) a press release reporting the filing of its annual report on Form
20-F for the fiscal year ended December 31, 2022, with the U.S. Securities and Exchange Commission. The Company's financial statements
and related financial information for the three months ended March 31, 2023 are unaudited or have not been reviewed by the Company's independent
registered accountant. These financial results could differ materially if they were reviewed by the Company’s independent registered
accountant.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
Fresh2 Group
Limited |
|
|
|
By: |
/s/
Haohan Xu |
|
Name: |
Haohan Xu |
|
Title: |
Co-Chief
Executive Officer |
|
|
|
Dated:
May 16, 2023 |
|
|
3
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Apr 2023 to Apr 2024